We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:LGND
​
​
logo

Ligand Pharmaceuticals Incorporated (LGND)

Nasdaq • LGND • US53220K5048

306.20Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 13.9% of free float sold short, 10.6 days to cover, cost to borrow 0.49%. Sign up for live short interest data.

Market Cap

6.12b USD | # 2192 in US

Volume

234.27k shares | 69.48m USD

Shares Outstanding

20m

Free Float Shares

97.74% | 19.55m

DB:LGDN

News

LGND key data

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) has a market capitalization of $6.12B. Last close $306.20 (as of 2026-11-09); 52-week range $175.89 to $326.63. ORTEX data as of 2026-10-22: short interest was 13.85% of free float, 10.6 days to cover and the average cost to borrow was 0.49%. Sign up for live short interest data.

  • LGND news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.